Anti-Suicide Drugs Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027

The global anti-suicide drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Anti-suicide drugs are anti-psychotic and anti-depressant drugs. They are prescribed to prevent patients from suicidal thoughts and attempts. Additionally, they are also given to cure the underlying conditions which lead a person to have suicidal tendencies. Furthermore, depression is one of the major reasons that lead to suicide. The major factor driving the demand for anti-suicide drugs is the increasing cases of suicide across the globe.

According to the American Foundation for Suicide Prevention, in 2019 suicide is the 10th leading cause of mortality in the US. Additionally, there was a mortality rate of 47,511 people from suicide in the US. Furthermore, there were 1.38 million suicide attempts with an age-adjusted suicide rate of 13.93 per 100,000 individuals in 2019. Hence, the increasing incidence of suicide is driving the demand for anti-suicide drugs which in turn is driving the growth of the market.

To Request a Sample of our Report on Anti-Suicide Drugs Market: https://www.omrglobal.com/request-sample/anti-suicide-drugs-market

Some major players in the market include Pfizer, Inc., Johnson & Johnson Services, Inc., and GlaxoSmithKline plc, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in August 2020, Janssen Pharmaceuticals, Inc. announced the approval of Spravato from the US Food and Drug Administration (FDA). Spravato is a nasal spray used for the treatment of suicidal patients with major depression.

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

• By Drug Class

• By Distribution Channel

Regions Covered-

• North America

• Europe

• Asia-Pacific

• Rest of the World

Competitive Landscape- Pfizer, Inc., Johnson & Johnson Services, Inc., and GlaxoSmithKline plc, among others.

(Get 15% Discount on Buying this Report)

A full Report of Anti-Suicide Drugs Market is Available @ https://www.omrglobal.com/industry-reports/anti-suicide-drugs-market

Global Anti-Suicide Drugs Market Report by Segment

By Drug Class

• Anti-Depressant and Anti-Anxiety Drugs

• N-Methyl-D-Aspartate (NMDA) Receptor Antagonists

• Antibiotic Analog

• Anti-Psychotic Drugs

• Others

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Global Anti-Suicide Drugs Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.